Balsm Alofoq Medical Company (TADAWUL:9620)
Saudi Arabia
· Delayed Price · Currency is SAR
28.90
+1.00 (3.58%)
Mar 10, 2026, 10:31 AM AST
TADAWUL:9620 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 70 | 93 | - | - |
| Enterprise Value | 53 | 89 | - | - |
| Last Close Price | 27.90 | 37.00 | - | - |
| PE Ratio | 13.64 | 19.35 | - | - |
| PS Ratio | 3.48 | 4.66 | - | - |
| PB Ratio | 2.30 | 3.20 | - | - |
| P/TBV Ratio | 2.30 | 3.20 | - | - |
| P/FCF Ratio | 19.54 | 17.55 | - | - |
| P/OCF Ratio | 18.16 | 16.87 | - | - |
| EV/Sales Ratio | 2.66 | 4.49 | - | - |
| EV/EBITDA Ratio | 8.59 | 14.75 | - | - |
| EV/EBIT Ratio | 10.59 | 17.43 | - | - |
| EV/FCF Ratio | 14.95 | 16.92 | - | - |
| Debt / Equity Ratio | 0.06 | 0.06 | 0.13 | 0.36 |
| Debt / EBITDA Ratio | 0.27 | 0.29 | 0.35 | 0.51 |
| Debt / FCF Ratio | 0.48 | 0.34 | - | 0.58 |
| Net Debt / Equity Ratio | -0.54 | -0.57 | -0.12 | -0.42 |
| Net Debt / EBITDA Ratio | -2.75 | -2.72 | -0.34 | -0.67 |
| Net Debt / FCF Ratio | -4.60 | -3.12 | 1.01 | -0.69 |
| Asset Turnover | 0.74 | 0.77 | 1.08 | - |
| Inventory Turnover | 4.88 | 6.51 | 9.06 | - |
| Quick Ratio | 14.69 | 11.51 | 2.64 | 1.39 |
| Current Ratio | 17.76 | 12.94 | 3.81 | 1.69 |
| Return on Equity (ROE) | 20.35% | 22.08% | 38.27% | - |
| Return on Assets (ROA) | 11.54% | 12.31% | 16.18% | - |
| Return on Invested Capital (ROIC) | 34.25% | 38.61% | 50.28% | 84.94% |
| Return on Capital Employed (ROCE) | 15.20% | 16.20% | 25.40% | 35.50% |
| Earnings Yield | 6.72% | 5.17% | - | - |
| FCF Yield | 5.12% | 5.70% | - | - |
| Dividend Yield | - | 4.05% | - | - |
| Payout Ratio | 63.98% | 62.76% | 23.07% | - |
| Buyback Yield / Dilution | -31.65% | -38.36% | - | - |
| Total Shareholder Return | -31.65% | -34.31% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.